Total Payments
$34,198
2024 Payments
$142.46
Companies
6
Transactions
31
Medicare Patients
394
Medicare Billing
$49,104
Payment Breakdown by Category
Research$19,365 (56.6%)
Consulting$11,374 (33.3%)
Travel$2,357 (6.9%)
Food & Beverage$1,102 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $19,365 | 2 | 56.6% |
| Consulting Fee | $11,374 | 5 | 33.3% |
| Travel and Lodging | $2,357 | 9 | 6.9% |
| Food and Beverage | $1,102 | 15 | 3.2% |
Payments by Type
Research
$19,365
2 transactions
General
$14,833
29 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cepheid | $19,365 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $4,800 | 11 | $0 (2024) |
| ViiV Healthcare Company | $3,900 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $3,322 | 1 | $0 (2020) |
| Janssen Research & Development, LLC | $1,979 | 15 | $0 (2022) |
| Dr.Reddy's Laboratories,Inc. | $832.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.46 | 2 | Gilead Sciences, Inc. ($142.46) |
| 2023 | $6,628 | 6 | ViiV Healthcare Company ($3,900) |
| 2022 | $3,908 | 19 | Janssen Research & Development, LLC ($1,979) |
| 2021 | $832.50 | 1 | Dr.Reddy's Laboratories,Inc. ($832.50) |
| 2020 | $3,322 | 1 | SANOFI-AVENTIS U.S. LLC ($3,322) |
| 2017 | $19,365 | 2 | Cepheid ($19,365) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $140.34 | General |
| 03/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.12 | General |
| 10/19/2023 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $685.90 | General |
| 10/19/2023 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $35.00 | General |
| 10/18/2023 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 10/14/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $106.78 | General |
| 10/14/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $40.74 | General |
| 05/02/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| 12/07/2022 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $297.72 | General |
| 11/05/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $224.60 | General |
| 11/05/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/05/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/05/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 11/05/2022 | Janssen Research & Development, LLC | — | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $206.31 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/04/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $206.31 | General |
| 11/03/2022 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 11/02/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,460.00 | General |
| 11/02/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $359.62 | General |
| 11/02/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $206.31 | General |
| 11/02/2022 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $135.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GeneXpert | Cepheid | $19,365 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 78 | 92 | $87,608 | $10,666 |
| 2022 | 5 | 76 | 100 | $76,311 | $10,408 |
| 2021 | 7 | 120 | 160 | $100,421 | $14,324 |
| 2020 | 5 | 120 | 161 | $99,420 | $13,707 |
Total Patients
394
Total Services
513
Medicare Billing
$49,104
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $30,961 | $3,286 | 10.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $30,237 | $3,220 | 10.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 25 | $16,245 | $2,763 | 17.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 19 | $10,165 | $1,397 | 13.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $21,678 | $2,461 | 11.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 26 | $14,950 | $2,379 | 15.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $17,278 | $2,202 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 20 | $10,100 | $1,853 | 18.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 23 | $12,305 | $1,513 | 12.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 42 | $23,270 | $4,045 | 17.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 36 | $19,260 | $2,414 | 12.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $20,697 | $2,321 | 11.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $15,838 | $2,073 | 13.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 19 | $9,475 | $1,679 | 17.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 12 | 16 | $7,520 | $973.92 | 13.0% |
| 99448 | Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 21-30 minutes of medical consultative discussion and review | Facility | 2021 | 18 | 18 | $4,360 | $817.60 | 18.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 38 | 38 | $43,695 | $4,700 | 10.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 34 | $16,830 | $3,305 | 19.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 48 | $21,600 | $3,122 | 14.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 19 | 29 | $12,905 | $1,764 | 13.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $4,390 | $816.68 | 18.6% |
About Dr. Barry Zingman, MD
Dr. Barry Zingman, MD is a Infectious Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699850461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Zingman, MD has received a total of $34,198 in payments from pharmaceutical and medical device companies, with $142.46 received in 2024. These payments were reported across 31 transactions from 6 companies. The most common payment nature is "" ($19,365).
As a Medicare-enrolled provider, Zingman has provided services to 394 Medicare beneficiaries, totaling 513 services with total Medicare billing of $49,104. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Bronx, NY
- Active Since 10/27/2006
- Last Updated 10/11/2011
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1699850461
Products in Payments
- GeneXpert (Medical Supply) $19,365
- Descovy (Drug) $171.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Bronx
Dr. Peter Alpert, Md, MD
Infectious Disease — Payments: $293,906
Infectious Disease $293,906
Mr. Norbert Brau, M.d, M.D
Infectious Disease — Payments: $180,229
Infectious Disease $180,229
Hernan Valdez, Md, MD
Infectious Disease — Payments: $36,939
Infectious Disease $36,939
Arturo Casadevall, Md, MD
Infectious Disease — Payments: $29,572
Infectious Disease $29,572
Dial Hewlett, Md, MD
Infectious Disease — Payments: $19,196
Infectious Disease $19,196
Julio Quintanilla, M.d, M.D
Infectious Disease — Payments: $16,077
Infectious Disease $16,077